Objective: To examine screening performance of California's triple-marker screening program, using data from a statewide registry for chromosomal defects.
Methods: This study included 752,686 women who received a screening risk and had an expected date of delivery between July 2005 and the end of June 2007. Follow-up diagnostic services for screen-positive women were performed at state-approved centers.